Cargando…

Non‐metabolic function of MTHFD2 activates CDK2 in bladder cancer

Bladder cancer is a common tumor with a high recurrence rate and high fatality rate, and its mechanism of occurrence and development remains unclear. Many proteins and metabolites reprogram at different stages of tumor development to support tumor cell growth. The moonlighting effect happens when a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Xi, Liu, Shuangjie, Piao, Chiyuan, Zhang, Zhe, Zhang, Xiaotong, Jiang, Yuanjun, Kong, Chuize
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645701/ https://www.ncbi.nlm.nih.gov/pubmed/34632667 http://dx.doi.org/10.1111/cas.15159

Ejemplares similares

Flavokawain A is a natural inhibitor of PRMT5 in bladder cancer
por: Liu, Shuangjie, et al.
Publicado: (2022)

USP13 functions as a tumor suppressor by blocking the NF-kB-mediated PTEN downregulation in human bladder cancer
por: Man, Xiaojun, et al.
Publicado: (2019)

Correction to: USP13 functions as a tumor suppressor by blocking the NF-kB-mediated PTEN downregulation in human bladder cancer
por: Man, Xiaojun, et al.
Publicado: (2021)

The Sigma‐2 Receptor/TMEM97 Agonist PB28 Suppresses Cell Proliferation and Invasion by Regulating the PI3K‐AKT‐mTOR Signalling Pathway in Renal Cancer
por: Zhan, Bo, et al.
Publicado: (2021)

Genome-Wide Analyses of Prognostic and Therapeutic Alternative Splicing Signatures in Bladder Urothelial Carcinoma
por: Fan, Zhongru, et al.
Publicado: (2021)

Overexpression of UNC5B in bladder cancer cells inhibits proliferation and reduces the volume of transplantation tumors in nude mice
por: Kong, Chuize, et al.
Publicado: (2016)

METTL13 inhibits progression of clear cell renal cell carcinoma with repression on PI3K/AKT/mTOR/HIF-1α pathway and c-Myc expression
por: Liu, Zhuonan, et al.
Publicado: (2021)

METTL14-mediated N(6)-methyladenosine modification of ITGB4 mRNA inhibits metastasis of clear cell renal cell carcinoma
por: Liu, Zhuonan, et al.
Publicado: (2022)

miR-130b, an onco-miRNA in bladder cancer, is directly regulated by NF-κB and sustains NF-κB activation by decreasing Cylindromatosis expression
por: Cui, Xiaolu, et al.
Publicado: (2016)

Inhibition of stearoyl CoA desaturase‐1 activity suppresses tumour progression and improves prognosis in human bladder cancer
por: Piao, Chiyuan, et al.
Publicado: (2018)

Caspase recruitment domain family member 10 regulates carbamoyl phosphate synthase 1 and promotes cancer growth in bladder cancer cells
por: Liu, Xi, et al.
Publicado: (2019)

RUNX2 interacts with SCD1 and activates Wnt/β‐catenin signaling pathway to promote the progression of clear cell renal cell carcinoma
por: Song, Xiandong, et al.
Publicado: (2022)

Silencing of CARMA3 inhibits bladder cancer cell migration and invasion via deactivating β-catenin signaling pathway
por: Man, Xiaojun, et al.
Publicado: (2019)

Association of Maternal Folate Intake and Offspring MTHFD1 and MTHFD2 Genes with Congenital Heart Disease
por: Liu, Hanjun, et al.
Publicado: (2023)

MTHFD2- a new twist?
por: Tedeschi, Philip M., et al.
Publicado: (2016)

Exploring the five different genes associated with PKCα in bladder cancer based on gene expression microarray
por: Zhang, Xiaotong, et al.
Publicado: (2021)

Upregulation of MTHFD2 is associated with PD-L1 activation in bladder cancer via the PI3K/AKT pathway
por: Deng, Xinxi, et al.
Publicado: (2022)

Targeting MTHFD2 in acute myeloid leukemia
por: Pikman, Yana, et al.
Publicado: (2016)

Reduction of protein kinase C α (PKC-α) promote apoptosis via down-regulation of Dicer in bladder cancer
por: Jiang, Zhenming, et al.
Publicado: (2015)

The effect of MTHFD2 on the proliferation and migration of colorectal cancer cell lines
por: Wei, Yameng, et al.
Publicado: (2019)

MTHFD2 is a potential oncogene for its strong association with poor prognosis and high level of immune infiltrates in urothelial carcinomas of bladder
por: Zhu, Lin, et al.
Publicado: (2022)

PPFIA4 promotes castration-resistant prostate cancer by enhancing mitochondrial metabolism through MTHFD2
por: Zhao, Ru, et al.
Publicado: (2022)

MTHFD2 promotes PD‐L1 expression via activation of the JAK/STAT signalling pathway in bladder cancer
por: Li, Linzhi, et al.
Publicado: (2023)

Targeted inhibition of Polo‐like kinase 1 by a novel small‐molecule inhibitor induces mitotic catastrophe and apoptosis in human bladder cancer cells
por: Zhang, Zhe, et al.
Publicado: (2016)

Deacetylation of MTHFD2 by SIRT4 senses stress signal to inhibit cancer cell growth by remodeling folate metabolism
por: Zhang, Fan, et al.
Publicado: (2022)

Expression and Role of Methylenetetrahydrofolate Dehydrogenase 1 Like (MTHFD1L) in Bladder Cancer
por: Eich, Marie-Lisa, et al.
Publicado: (2019)

The intracellular domain of UNC5B facilities proliferation and metastasis of bladder cancer cells
por: Huang, Yexiang, et al.
Publicado: (2020)

METTL14 promotes migration and invasion of choroidal melanoma by targeting RUNX2 mRNA via m6A modification
por: Zhang, Xi, et al.
Publicado: (2022)

Triglyceride regulate ACE2 level through MTHFD1
por: Ma, Xiaohua, et al.
Publicado: (2021)

The catalytic mechanism of the mitochondrial methylenetetrahydrofolate dehydrogenase/cyclohydrolase (MTHFD2)
por: Zhao, Li Na, et al.
Publicado: (2022)

Down-regulation LncRNA-SNHG15 contributes to proliferation and invasion of bladder cancer cells
por: Mokhtar, Aldhabi, et al.
Publicado: (2021)

More Than a Metabolic Enzyme: MTHFD2 as a Novel Target for Anticancer Therapy?
por: Zhu, Zhiyuan, et al.
Publicado: (2020)

MicroRNA-16-5p/BIMP1/NF-κB axis regulates autophagy to exert a tumor-suppressive effect on bladder cancer
por: He, Jiani, et al.
Publicado: (2021)

Expression and Prognostic Value Identification of Methylenetetrahydrofolate Dehydrogenase 2 (MTHFD2) in Brain Low-Grade Glioma
por: Shi, Lu-feng, et al.
Publicado: (2021)

Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer
por: Nilsson, Roland, et al.
Publicado: (2014)

The Prognostic Significance of Immune-Related Metabolic Enzyme MTHFD2 in Head and Neck Squamous Cell Carcinoma
por: Cui, Li, et al.
Publicado: (2020)

Mthfd2 Modulates Mitochondrial Function and DNA Repair to Maintain the Pluripotency of Mouse Stem Cells
por: Yue, Liang, et al.
Publicado: (2020)

Oxidized phospholipids regulate amino acid metabolism through MTHFD2 to facilitate nucleotide release in endothelial cells
por: Hitzel, Juliane, et al.
Publicado: (2018)

METTL13 is downregulated in bladder carcinoma and suppresses cell proliferation, migration and invasion
por: Zhang, Zhe, et al.
Publicado: (2016)

MTHFD2 facilitates breast cancer cell proliferation via the AKT signaling pathway
por: Huang, Jun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mj8itt83qgd220n90vahjhdifg